Done sou Salè H1B

Akèy › Metiyè › Medical Scientists, Except Epidemiologists › San Diego, CA

Medical Scientists, Except Epidemiologists nan San Diego, CA: Salè H-1B

73 aplikasyon kondisyon travay pou okipasyon sa a ak yon sit travay nan San Diego, CA. Salè baz medyàn ofri $112,000; mwatye mitan $86,000–$140,000.

Demann (LCA)73
Salè medyan ofri$112,000
Mwatye salè yo$86,000–$140,000
10yèm–90yèm pousantaj$74,396–$190,680

Pa nivo salè

Nivo revniSalè medyan
Nivo I (antre)$75,587
Nivo II (kalifye)$110,000
Nivo III (eksperyans)$130,800
Nivo IV (plen kompetans)$173,856

Depatman Travay la etabli kat nivo salè prevanlan pou chak okipasyon ak zòn, soti nan Nivo I (antre) rive nan Nivo IV (plen kompetans). Anplwayè a chwazi nivo ki koresponn ak kondisyon travay la.

Anplwayè yo

AnplwayèLCASalè medyan
University of California, San Diego9$81,000
Neurocrine Biosciences, Inc.7$125,000
Bristol-Myers Squibb Company5$149,350
Takeda Development Center Americas, Inc.4$134,472
Vertex Pharmaceuticals Incorporated4$103,759
Janssen Research & Development, LLC4$177,750
Novartis Institutes for BioMedical Research, Inc.3$119,850
The University of Southern California3$75,587
Eli Lilly and Company3$260,000
Capstan Therapeutics, Inc2$106,642
Odyssey Therapeutics Inc2$150,000
HD Biosciences, Inc.2$85,000
Emory University2$93,454
The Scintillon Institute2$75,587
OliX US, Inc.2$101,000
ImmunityBio, Inc.2$86,000
Atmo Biosciences Inc1$83,950
Takeda California, Inc.1$125,399
Organovo, Inc.1—
Northwestern University1$56,484
San Diego State University Research Foundation1$62,400
The California Medical Innovations institute Inc.1—
Elly Health, Inc.1$100,000
Brain Cancer Research Institute1$53,206
Zeno Management, Inc.1$125,000
Becton, Dickinson and Company1$141,000
Cosmobiolabs Inc.1$110,000
Aspen Neuroscience Inc.1$112,687
Pfizer Inc.1$94,702
International AIDS Vaccine Initiative (IAVI)1$110,000
Blueprint Medicines Corporation1$200,790
Enqubio Inc1$127,500
Insmed Gene Therapy LLC1$145,000

Tit travay

Pwonse H-1B nan San Diego, CA →

Salè yo se fen ki pi ba nan salè yo ofri sou chak aplikasyon, konvèti nan yon montan anyèl; estatistik yo itilize sèlman aplikasyon tan plen sètifye. Yon LCA pa yon apwobasyon visa epi yon sèl LCA ka kouvri plizyè pozisyon. Sous: Depatman Travay Etazini, Done Divulgasyon LCA OFLC, ane fiskal 2023–2026 (dènye desizyon Jun 30, 2026).